SCHEDULE OF WARRANT ACTIVITY (Details) - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Equity [Abstract] | ||
| Weighted Average Exercise Price at beginning | $ 0.74 | $ 0.67 |
| Number of Warrants at Beginning | 271,000 | 1,221,000 |
| Weighted Average Remaining Contractual Life Warrants Outstanding | 1 year | |
| Weighted Average Exercise Price, Granted | ||
| Number of Warrants Granted | ||
| Weighted Average Exercise Price, Exercised | ||
| Number of Warrants Exercised | ||
| Weighted Average Exercise Price, Cancelled | $ 0.85 | $ 0.65 |
| Number of Warrants Cancelled | (71,000) | (950,000) |
| Weighted Average Remaining Contractual Life Warrants Outstanding Ending | 1 year 6 months | |
| Weighted Average Exercise Price at ending | $ 0.70 | $ 0.74 |
| Number of Warrants at Ending | 200,000 | 271,000 |
| Weighted Average Remaining Contractual Life Warrants Vested and exercisable | 8 months 12 days | |
| Weighted Average Exercise, Vested and exercisable at end | $ 0.70 | |
| Number of Warrants, Vested and exercisable at end | 200,000 | |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments cancelled in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments exercised in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments vested and exercisable in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments granted in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of non-option equity outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for non-option equity awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for non-option equity awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Net number of non-option equity instruments vested and to exercisable participants. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|